Researchers take key step toward growing human organs in laboratory

Researchers have learned that precursor cells for skeletal muscles actually also give rise to neurons, blood vessels, blood cells and immune cells, pushing science one step closer to generating body parts in a laboratory.

Oilseed crop’s waste product yields compounds that protect skin from the sun

Meadowfoam, a native Pacific Northwest plant cultivated as an oilseed crop, has emerged as a potential new source of protection against the sun’s harmful effects on the skin.

Cell-penetrating “nanodrills” show promise for intracellular drug delivery

Researchers have created new nanomaterials able to cross cell membranes, establishing a novel platform for the intracellular delivery of molecular drugs and other cargo.

Researchers take important step toward gonorrhea vaccine

Researchers are paving the way toward a new therapeutic approach for gonorrhea by shedding light on the mechanism behind important proteins on the Neisseria gonorrhoeae bacteria’s outer membrane. 

Conference at OSU explores intravenous vitamin C as treatment for cancer, sepsis

The Linus Pauling Institute will host its biennial “Diet and Optimum Health” conference Sept. 13-16, attracting an international audience of experts in nutrition, preventive medicine and oncology.

Oregon State University agricultural sciences, pharmacy deans transition

Dan Arp, dean of the College of Agricultural Sciences, and Mark Zabriskie, dean of the College of Pharmacy, will step down from these university leadership roles effective June 30, 2018. 

New gonorrhea treatment targets enzyme needed for respiration

Researchers have identified a possible new treatment for gonorrhea, using a peptide that thwarts the infection-causing bacterium by interfering with an enzyme the microbe needs to respirate.

Patients nearing end of life receptive to having cholesterol medicine 'deprescribed'

Research suggests patients nearing the end of their lives because of a “life-limiting illness” may not feel medically abandoned if their doctor wants to take them off cholesterol medicine.

Blocking TB germs' metabolic 'escape pathways' may be key to better, shorter treatment

Research suggests the bacteria that cause TB alter their metabolism to combat exposure to antimicrobials, and that the metabolic mechanisms might be neutralized by new drugs.

Pages